Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic prurigo
L. Misery
British Journal of Dermatology (2022) Vol. 187, Iss. 4, pp. 464-471
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Shawn G. Kwatra, Gil Yosipovitch, Franz J. Legat, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 17, pp. 1579-1589
Closed Access | Times Cited: 58
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
Howard Sofen, Robert Bissonnette, Gil Yosipovitch, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101826-101826
Open Access | Times Cited: 45
Basic mechanisms of itch
L. Misery, Ophélie Pierre, C. Le Gall‐Ianotto, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 1, pp. 11-23
Open Access | Times Cited: 37
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Svenja Müller, Claudia Zeidler, Sonja Ständer
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 15-33
Open Access | Times Cited: 30
Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study
Henning Olbrich, Khalaf Kridin, Gema Hernández, et al.
EBioMedicine (2024) Vol. 103, pp. 105123-105123
Open Access | Times Cited: 8
Effectiveness and Safety of Dupilumab for Prurigo Nodularis in China: A Multicentric and Observational Study
Zuotao Zhao, Xiaoting Song, Yuanyuan Shang, et al.
Allergy (2025)
Open Access | Times Cited: 1
Molecular mechanisms of pruritus in prurigo nodularis
Yixin Shao, Duoqin Wang, Yiqi Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
The involvement of keratinocytes in pruritus of chronic inflammatory dermatosis
Shiying Lin, Xin Liu, Jiang Jian, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 7
Open Access | Times Cited: 4
Scratching more than an itch
Aaron Ver Heul
Science (2025) Vol. 387, Iss. 6733, pp. 473-474
Closed Access
Functional Magnetic Resonance Imaging in Prurigo Nodularis: A Systematic Review
Xuanyu Zhao, Jannis M. Mueller, Simon M. Mueller
Clinics in Dermatology (2025)
Closed Access
Prurigo Nodularis: A historic perspective
Sarah G Brooks, Giulia Coscarella, Gil Yosipovitch
Clinics in Dermatology (2025)
Closed Access
Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data
Cataldo Patruno, Claudio Pelucchi, Carlotta Galeone, et al.
Dermatology Practical & Conceptual (2025) Vol. 15, pp. 4716-4716
Open Access
Chronic prurigo: current insights and future directions
Lea-Sophie Stahl, Sonja Ständer, Claudia Zeidler
Journal of the Egyptian Womenʼs Dermatologic Society (2025) Vol. 22, Iss. 2, pp. 99-105
Open Access
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics
Hwa Jung Yook, Ji Hyun Lee
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5164-5164
Open Access | Times Cited: 3
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Sonja Ständer, Gil Yosipovitch, Franz J. Legat, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 3
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis
Mohammad Ali Nilforoushzadeh, Nazila Heidari, Yekta Ghane, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 991-1003
Closed Access | Times Cited: 2
Prurigo: review of its pathogenesis, diagnosis, and treatment
Paulo Ricardo Criado, Mayra Ianhez, Roberta Fachini Jardim Criado, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 5, pp. 706-720
Open Access | Times Cited: 2
Chronic prurigo: Insufficient disease control in spite of high healthcare usage
Manuel P. Pereira, Elke Weißhaar, Jon Anders Halvorsen, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 6
Open Access | Times Cited: 4
Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study
Lu Wei, Mengting Yin, Xu Yang, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 10, pp. 799-805
Closed Access | Times Cited: 2
Prurigo nodularis forecast: Light type 2 inflammation with high chances of fibrosis
Curdin Conrad, Christoph Schlapbach
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 1, pp. 93-94
Closed Access | Times Cited: 2
Construction of a disease risk prediction model for postherpetic pruritus by machine learning
Zheng Lin, Yuan Dou, Robert J. Ju, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Prurigo: revisão de sua patogênese, diagnóstico e tratamento
Paulo Ricardo Criado, Mayra Ianhez, Roberta Fachini Jardim Criado, et al.
(2024) Vol. 99, Iss. 5, pp. 706-720
Open Access
Treatment of chronic nodular prurigo with intravenous naloxone during pregnancy
Svenja Müller, Waltraut M. Merz, Philipp Lutz, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 7
Closed Access | Times Cited: 1
Impact of chronic prurigo nodularis on daily life and stigmatization
L. Misery, Christine Patras de Campaigno, C. Taïeb, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 7
Open Access | Times Cited: 1
Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France
L. Misery, Christine Patras de Campaigno, D. Jullien, et al.
JEADV Clinical Practice (2023) Vol. 2, Iss. 2, pp. 392-398
Open Access
Page 1 - Next Page

Scroll to top